ClinicalTrials.gg
CompletedNCT02193165Updated Aug 17, 2015Results posted

The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis

A Phase 3 interventional study of triclosan/fluoride toothpaste + cetylpyridinium chloride Mouthwash and stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash in Dental Plaque and Gingivitis, sponsored by Colgate Palmolive. Completed at 1 site in Puerto Rico. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-17.

Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 34 studies in Dental Plaque by Colgate Palmolive — 2 open to participants now, 3 under way, 3 of them phase 3. Dental Plaque · Colgate Palmolive.

Enrollment
6th of 34
120 · median 85
Started
2014
with 3 others
Phase 3
26 of 34
2 open now
Registered
13th of 34
by date

Among the 34 studies in Dental Plaque by Colgate Palmolive, this one is the 6th largest by enrollment, is one of 4 that started in 2014, is one of 26 in phase 3, and was the 13th registered.

Dental Plaque

352 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.

Browse Dental Plaque studies →

Open to participants now

2 of the 34 studies in Dental Plaque by Colgate Palmolive are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Who these studies take

Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.

This study: 21 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Dental Plaque by Colgate Palmolive, or all of them as a file.
02

Study summary

The objective of this clinical research study is to assess the efficacy of three oral hygiene multi-component regimens encompassing the use of a manual toothbrush, toothpaste and a mouthwash in controlling established dental plaque and gingivitis.

03

Conditions studied

  • Dental Plaque
  • Gingivitis
04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male and female subjects, ages 21-70, inclusive.
  2. Availability for the six-week duration of the study.
  3. Good general health.
  4. Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  5. Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  6. Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
  7. Signed Form.

Exclusion criteria

Exclusion Criteria:

  1. Presence of orthodontic bands.
  2. Presence of partial removable dentures.
  3. Tumor(s) of the soft or hard tissues of the oral cavity.
  4. Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  5. Five or more carious lesions requiring immediate restorative treatment.
  6. Use of antibiotics any time during the one month prior to entry into the study.
  7. Participation in any other clinical study or test panel within the one month prior to entry into the study.
  8. Pregnant women or women who are breast feeding.
  9. Dental prophylaxis received in the past two weeks prior to baseline examinations.
  10. History of allergies to oral care/personal care consumer products or their ingredients.
  11. On any prescription medicines that might interfere with the study outcome.
  12. An existing medical condition which prohibits eating or drinking for periods up to 4 hours.
  13. History of alcohol or drug abuse
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    Regimen 1

    triclosan/fluoride toothpaste + cetylpyridinium chloride Mouthwash

    Drug: triclosan/fluoride toothpaste + cetylpyridinium chloride Mouthwash

  • Active comparator
    Regimen 2

    stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash

    Drug: stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash

  • Placebo comparator
    Regimen 3 - Control group

    fluoride toothpaste + fluoride Mouthwash

    Drug: fluoride toothpaste + fluoride Mouthwash

Interventions

  • Drugtriclosan/fluoride toothpaste + cetylpyridinium chloride Mouthwash

    Brush whole mouth with Total toothpaste for 1 minute, 2 times/day for 6 weeks (study duration) using a Total 360 toothbrush. Immediately after each toothbrushing, rinse whole mouth with 20 ml of mouthwash for 30 seconds.

    Also known as: Total toothpaste, Total Mouthwash

  • Drugstannous fluoride toothpaste + cetylpyridinium chloride Mouthwash

    Drug page: Tin Fluorides

    Brush whole mouth with Crest Pro-Health toothpaste for 1 minute, 2 times/day for 6 weeks (study duration) using an Oral B Pro-Health toothbrush. Immediately after each toothbrushing, rinse whole mouth with 20 ml of Crest Pro-Health Multi-Protection mouthwash for 30 seconds.

    Also known as: Crest Pro-Health toothpaste, Crest Pro-Health Multi-Protection Mouthwash

  • Drugfluoride toothpaste + fluoride Mouthwash

    Brush whole mouth with Crest Cavity Protection toothpaste for 1 minute, 2 times/day for 6 weeks (study duration) using an Oral B Indicator toothbrush. Immediately after each toothbrushing, rinse whole mouth with 20 ml of Crest Pro-Health For Me Breezy Mint mouthwash for 30 seconds.

    Also known as: Crest Cavity Protection toothpaste, Crest Pro-Health For Me Breezy Mint mouthwash

06

What researchers measure

Primary outcomes

  1. Dental Plaque Scores

    Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

    Time frame: Baseline

  2. Dental Plaque Scores

    Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

    Time frame: 4 weeks

  3. Dental Plaque Scores

    Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

    Time frame: 6 weeks

  4. Gingivitis Scores

    Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

    Time frame: Baseline

  5. Gingivitis Scores

    Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

    Time frame: 4 weeks

  6. Gingivitis Scores

    Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

    Time frame: 6 weeks

07

Results

Posted Feb 6, 2015

Participant flow

recruitment at clinical site

4 Week Product Use
Participant flow — 4 Week Product Use
MilestoneRegimen 1Regimen 2Regimen 3 - Control Group
Started404040
Completed393939
Not completed111
Withdrew: Lost to follow-up111
6 Week Product Use
Participant flow — 6 Week Product Use
MilestoneRegimen 1Regimen 2Regimen 3 - Control Group
Started393939
Completed393839
Not completed010
Withdrew: Lost to follow-up010

Outcome measures

PrimaryDental Plaque Scores

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Time frame:
Baseline
Reported as:
Mean · units on a scale
Dental Plaque Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Dental Plaque Scores3.33 ± 0.523.19 ± 0.533.31 ± 0.48
Statistical analysis
  • Regimen 1 vs Regimen 2 vs Regimen 3 - Control Group · ANOVA · p = 0.434
PrimaryDental Plaque Scores

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Time frame:
4 weeks
Reported as:
Mean · units on a scale
Dental Plaque Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Dental Plaque Scores2.78 ± 0.562.79 ± 0.523.34 ± 0.48
Statistical analysis
  • Regimen 2 vs Regimen 3 - Control Group · ANCOVA · p = <0.001 (1 factor ANCOVA to determine difference between groups with baseline as covariate. The F statistic is used to determine significance. If significance is found then a Tukey's multiple comparison is done.)
PrimaryDental Plaque Scores

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Time frame:
6 weeks
Reported as:
Mean · units on a scale
Dental Plaque Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Dental Plaque Scores2.42 ± 0.622.59 ± 0.583.38 ± 0.49
Statistical analysis
  • Regimen 1 vs Regimen 2 vs Regimen 3 - Control Group · ANCOVA · p = <0.001 (1 factor ANCOVA to determine difference between groups with baseline as covariate. The F statistic is used to determine significance. If significance is found then a Tukey's multiple comparison is done.)
PrimaryGingivitis Scores

Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Time frame:
Baseline
Reported as:
Mean · units on a scale
Gingivitis Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Gingivitis Scores1.40 ± 0.311.40 ± 0.321.44 ± 0.37
Statistical analysis
  • Regimen 1 vs Regimen 2 vs Regimen 3 - Control Group · ANOVA · p = 0.816
PrimaryGingivitis Scores

Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Time frame:
4 weeks
Reported as:
Mean · units on a scale
Gingivitis Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Gingivitis Scores1.19 ± 0.231.30 ± 0.271.44 ± 0.37
Statistical analysis
  • Regimen 1 vs Regimen 2 vs Regimen 3 - Control Group · ANCOVA · p = <0.001 (1 factor ANCOVA to determine difference between groups with baseline as covariate. The F statistic is used to determine significance. If significance is found then a Tukey's multiple comparison is done.)
PrimaryGingivitis Scores

Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Time frame:
6 weeks
Reported as:
Mean · units on a scale
Gingivitis Scores
units on a scaleRegimen 1Regimen 2Regimen 3 - Control Group
Gingivitis Scores1.03 ± 0.141.21 ± 0.241.46 ± 0.36
Statistical analysis
  • Regimen 1 vs Regimen 2 vs Regimen 3 - Control Group · ANCOVA · p = <0.001 (1 factor ANCOVA to determine difference between groups with baseline as covariate. The F statistic is used to determine significance. If significance is found then a Tukey's multiple comparison is done.)

Adverse events

Collected over 6 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Regimen 1—0/40 (0%)0/40 (0%)
Regimen 2—0/40 (0%)0/40 (0%)
Regimen 3 - Control Group—0/40 (0%)0/40 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Regimen 1Regimen 2Regimen 3 - Control GroupTotal
<=18 years0000
Between 18 and 65 years393839116
>=65 years1214
Sex: Female, Male
Sex: Female, Male(Participants)Regimen 1Regimen 2Regimen 3 - Control GroupTotal
Female17161447
Male23242673
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Regimen 1Regimen 2Regimen 3 - Control GroupTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White404040120
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Regimen 1Regimen 2Regimen 3 - Control GroupTotal
United States404040120
08

Study locations

1 site
  • Centro Comercial Plaza Trujillo
    Trujillo Alto, 00976, Puerto Rico
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2014, a primary completion of Aug 2014 and a completion of Aug 2014. It does not say whether these dates are actual or estimated.

Results were first posted in Feb 2015, 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2014
First posted
Jul 17, 2014
Start
Jul 2014
Primary completionActual
Aug 2014
CompletionActual
Aug 2014
Results first posted
Feb 6, 2015
Last update
Aug 17, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02193165
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Jul 17, 2014
Start date
Jul 2014
Primary completion
Aug 2014
Completion
Aug 2014
Results posted
Feb 6, 2015
Last update
Aug 17, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion